Crossmark

Preoperative Denosumab Therapy Against Giant Cell Tumor of Bone is Associated with an Increased Risk of Local Recurrence After Curettage Surgery

Published Online: 2022-02-17

Published Print: 2022-06

Authors

Asano, Naofumi https://orcid.org/0000-0002-8127-3275
Saito, Masato

Kobayashi, Eisuke

Morii, Takeshi

Kikuta, Kazutaka

Watanabe, Itsuo

Anazawa, Ukei

Takeuchi, Katsuhito

Suzuki, Yoshihisa

Susa, Michiro

Nishimoto, Kazumasa

Ishii, Ryota

Miyazaki, Naoki

Mrioka, Hideo

Kawai, Akira

Horiuchi, Keisuke

Nakayama, Robert
License Information

Text and Data Mining valid from 2022-02-17

Version of Record valid from 2022-02-17
More Information

Article History

Received: 6 July 2021

Accepted: 18 January 2022

First Online: 17 February 2022

Disclosures

: The authors declare that they have no competing interests.

Document is current